将要访问
https://www.gilead.com/news-and-press/press-room/press-releases/2020/4/gilead-announces-results-from-phase-3-trial-of-investigational-antiviral-remdesivir-in-patients-with-severe-covid-19
此网页未在微博完成域名备案，可能存在内容风险。
如要继续访问，请注意您的隐私及财产安全。